Cargando…
Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study
Objective To compare the cumulative incidence of cervical cancer diagnosed within 72 months after a normal screening sample between conventional cytology and liquid based cytology tests SurePath and ThinPrep. Design Retrospective population based cohort study. Setting Nationwide network and registry...
Autores principales: | Rozemeijer, Kirsten, Naber, Steffie K, Penning, Corine, Overbeek, Lucy I H, Looman, Caspar W N, de Kok, Inge M C M, Matthijsse, Suzette M, Rebolj, Matejka, van Kemenade, Folkert J, van Ballegooijen, Marjolein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421440/ https://www.ncbi.nlm.nih.gov/pubmed/28196844 http://dx.doi.org/10.1136/bmj.j504 |
Ejemplares similares
-
Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates
por: Rozemeijer, Kirsten, et al.
Publicado: (2015) -
Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark
por: Rebolj, Matejka, et al.
Publicado: (2015) -
Can an inadequate cervical cytology sample in ThinPrep be converted to a satisfactory sample by processing it with a SurePath preparation?
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2017) -
Unsatisfactory rates vary between cervical cytology samples prepared using ThinPrep and SurePath platforms: a review and meta-analysis
por: Fontaine, Daniel, et al.
Publicado: (2012) -
Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis
por: Naber, Steffie K., et al.
Publicado: (2016)